As of Mar 23
| +0.15 / +1.17%|
The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 13.50, with a high estimate of 14.00 and a low estimate of 9.00. The median estimate represents a +4.25% increase from the last price of 12.95.
The current consensus among 6 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.